We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $900B Turnover 27.93%
1-Year Est. Return 28.45%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+0.94%
1 Year Est. Return
+28.45%
3 Year Est. Return
+123.38%
5 Year Est. Return
+136.75%
10 Year Est. Return
+480.78%
AUM
$900B
AUM Growth
+$24.6B
Cap. Flow
+$10B
Cap. Flow %
1.11%
Top 10 Hldgs %
22.27%
Holding
15,935
New
2,359
Increased
6,026
Reduced
5,358
Closed
2,092
Avg Time Held Equity + Options
3.6 years
Top 10 Avg Time Held Equity + Options
4.5 years
Top 20 Avg Time Held Equity + Options
5.3 years
Avg Time Held Equity only
2 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.4 years

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$2.3B
2
AMZN icon
Amazon
AMZN
+$1.55B
3
EA icon
Electronic Arts
EA
+$1.21B
4
AAPL icon
Apple
AAPL
+$877M
5
ABT icon
Abbott
ABT
+$720M

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.77%
2 Technology 4.02%
3 Healthcare 2.55%
4 Industrials 2.23%
5 Financials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LRN icon
2051
Stride
LRN
$3.14B
$30.9M ﹤0.01%
395,626
+246,910
+166% +$20.8M
2022 Q4
15 quarters
AU icon
2052
CALL
AngloGold Ashanti
AU
$36.6B
$30.8M ﹤0.01%
328,300
-186,600
-36% -$17.7M
2016 Q2
41 quarters
SFM icon
2053
CALL
Sprouts Farmers Market
SFM
$4.5B
$30.8M ﹤0.01%
464,700
+162,000
+54% +$12.7M
2013 Q3
52 quarters
UNF icon
2054
Unifirst
UNF
$4.13B
$30.8M ﹤0.01%
123,030
-79,024
-39% -$22.1M
2019 Q1
30 quarters
CAH icon
2055
PUT
Cardinal Health
CAH
$63.1B
$30.8M ﹤0.01%
138,500
-15,600
-10% -$3.63M
2013 Q2
53 quarters
ROL icon
2056
Rollins
ROL
$18.1B
$30.8M ﹤0.01%
1,021,675
-871,740
-46% -$32.7M
2017 Q4
35 quarters
WAB icon
2057
Wabtec
WAB
$45.2B
$30.8M ﹤0.01%
107,151
+8,633
+9% +$2.45M
2021 Q2
21 quarters
KGC icon
2058
PUT
Kinross Gold
KGC
$20.4B
$30.7M ﹤0.01%
1,276,900
-45,700
-3% -$1.22M
2013 Q2
53 quarters
BUD icon
2059
AB InBev
BUD
$156B
$30.7M ﹤0.01%
418,489
-1,076,864
-72% -$86.1M
2020 Q3
24 quarters
BRBR icon
2060
BellRing Brands
BRBR
$1.7B
$30.7M ﹤0.01%
3,994,201
-403,754
-9% -$4.46M
2020 Q4
23 quarters
CAH icon
2061
CALL
Cardinal Health
CAH
$63.1B
$30.7M ﹤0.01%
137,900
-30,600
-18% -$7.11M
2013 Q2
53 quarters
TTE icon
2062
PUT
TotalEnergies
TTE
$187B
$30.7M ﹤0.01%
358,800
+7,500
+2% +$649K
2016 Q2
41 quarters
CQQQ icon
2063
Invesco China Technology ETF
CQQQ
$1.6B
$30.7M ﹤0.01%
+682,994
New +$34.1M
2026 Q3
0 quarters
CL icon
2064
PUT
Colgate-Palmolive
CL
$78.5B
$30.7M ﹤0.01%
359,300
+28,000
+8% +$2.53M
2013 Q2
53 quarters
GDDY icon
2065
CALL
GoDaddy
GDDY
$12.1B
$30.6M ﹤0.01%
320,900
+187,300
+140% +$17.8M
2015 Q2
45 quarters
CART icon
2066
Maplebear
CART
$13.6B
$30.6M ﹤0.01%
710,105
-597,705
-46% -$28.2M
2023 Q3
12 quarters
ING icon
2067
ING
ING
$83.5B
$30.5M ﹤0.01%
859,505
+784,444
+1,045% +$27.3M
2025 Q3
4 quarters
LCID icon
2068
PUT
Lucid Group
LCID
$991M
$30.5M ﹤0.01%
7,486,310
+5,917,590
+377% +$33.5M
2021 Q1
22 quarters
SILJ icon
2069
PUT
Amplify Junior Silver Miners ETF
SILJ
$2.38B
$30.4M ﹤0.01%
1,115,900
-712,100
-39% -$20.1M
2020 Q2
25 quarters
TRGP icon
2070
CALL
Targa Resources
TRGP
$59.7B
$30.4M ﹤0.01%
112,500
-88,100
-44% -$24.7M
2013 Q3
52 quarters
MPT icon
2071
Medical Properties Trust
MPT
$1.03B
$30.4M ﹤0.01%
8,784,863
+7,523,770
+597% +$31.6M
2025 Q2
5 quarters
TNDM icon
2072
Tandem Diabetes Care
TNDM
$1.22B
$30.4M ﹤0.01%
1,861,707
+125,828
+7% +$2.36M
2018 Q2
33 quarters
TEVA icon
2073
Teva Pharmaceutical Industries
TEVA
$45.8B
$30.3M ﹤0.01%
766,167
+692,863
+945% +$24.8M
2026 Q2
1 quarter
AXSM icon
2074
PUT
Axsome Therapeutics
AXSM
$6.8B
$30.3M ﹤0.01%
164,500
+8,200
+5% +$1.78M
2019 Q1
30 quarters
UCO icon
2075
PUT
ProShares Ultra Bloomberg Crude Oil
UCO
$393M
$30.3M ﹤0.01%
567,900
-220,800
-28% -$9.6M
2016 Q3
40 quarters

Similar funds

Ken Griffin's Q3 2026 Portfolio in Review

As of Q3 2026, Ken Griffin held 15,935 positions worth $900B, up 2.8% from $875B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Ken Griffin's Q3 2026 filing shows 2,359 new, 6,026 increased, 5,358 reduced and 2,092 closed positions. Its largest new stake was ARK Innovation ETF: 10,014,859 shares worth $892M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.3B.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 83% a quarter earlier, followed by Technology and Healthcare.

  • Ken Griffin's largest Q3 2026 buy was ARK Innovation ETF: 10,014,859 shares worth $892M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $2.19B increase.
  • Ken Griffin's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.3B.
  • Ken Griffin fully exited Electronic Arts in Q3 2026, selling an estimated $1.21B.
  • Ken Griffin's ten largest holdings make up 22% of its $900B portfolio in Q3 2026.
  • Ken Griffin opened 2,359 new positions and closed 2,092 in Q3 2026.
  • Ken Griffin's portfolio value rose 2.8% quarter-over-quarter to $900B.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.